When does the body clock begin to synchronize with local time?
New research from Washington University in St. Louis shows that a mother helps to set the biological clock for her babies while they are still in the womb.
Grant furthers novel therapeutic approach to glioblastoma
Milan G. Chheda, MD, at WashU Medicine and a brain tumor specialist at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, has received a nearly $1.5 million grant from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation.
New software safeguards research participants’ privacy
WashU Medicine researchers have developed a software, De-ID, that flags sensitive information in data collected through focus groups, surveys and interviews. It allows for easy removal of such details to enable safe sharing.
Chemical compound clears cellular waste, protects neurons in model of frontotemporal dementia
New research from WashU Medicine adds to growing evidence that helping brain cells break down and eliminate their own cellular waste is a promising treatment strategy for a variety of neurodegenerative diseases.
‘Such a relief to finally know happiness’
The CONNECT program at WashU Medicine streamlines clinical services to provide timely, research-based mental health care that helps teens who have experienced trauma and suicide ideation.
Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation
Developed by WashU Medicine researchers and licensed to WashU startup Wugen, the immunotherapy is designed to treat rare and aggressive types of blood cancer.
Ackerman receives innovation in neuroscience award
Sarah Ackerman, at WashU Medicine, has been named a winner of the Maximizing Innovation in Neuroscience Discovery Prize by the Pershing Square Foundation.
Eleven WashU faculty elected to AAAS
Eleven WashU faculty members are among the new fellows selected by the American Association for the Advancement of Science, one of the most distinct honors in the scientific community.
Stopping GLP-1 drugs can quickly erase cardiovascular benefits
WashU Medicine researchers found that stopping GLP-1 drugs such as semaglutide and tirzepatide — even temporarily — elevates the risk of heart attack, stroke and death compared to staying on the medication continuously.
Levy appointed executive vice chancellor for medical affairs, dean of WashU Medicine
Bruce D. Levy, MD, a highly regarded leader in academic medicine and an accomplished physician-scientist, has been named executive vice chancellor for medical affairs and dean of Washington University School of Medicine in St. Louis. He begins his new role July 1, announced Chancellor Andrew D. Martin.
View More Stories